Powerful words today from Gabriel Fabreau MD, MPH, FRCPC on Alberta’s rising COVID numbers #ableg #COVID19AB (full story here: globalnews.ca/video/7785395/…)

Really nice to see important data out. Been using dosing since presented at ASCO 2019. Efficacy of Reduced-Intensity Chemotherapy Among Older and Frail Patients With Advanced Gastroesophageal... ja.ma/2SFyRr6 via JAMA Oncology part of JAMA Network

Our report w/ Choosing Wisely Canada recommends to NOT delay or avoid #PalliativeCare for patients w/ metastatic #cancer. Discover the other 19 recommendations to help decision-makers avoid reintroducing low-value services after #COVID ⬇️ cadth.info/33I7S0y

This is FANTASTIC! Updated USPSTF Guidelines for Colorectal Cancer Screening starting at age 45 y/o ja.ma/2S2Iyjh via JAMA Surgery part of JAMA Network OncoAlert @VUMC_Cancer Vanderbilt Health #colorectal #cancerprevention #cancer #EAOCRC #savealife #cancerscreening

Addition of Diet and Lifestyle Factors to Recurrence and Mortality Prediction Models for Patients With Stage III Colon Cancer ascopost.com/news/january-2… #crcsm #oncology #cancer

Current Issue: Efficacy and Safety of First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis buff.ly/3MiFIhu Matt Warkentin Chun Loo Gan @zencancermd Daniel Heng Darren Brenner #renalcell #carcinoma #MedTwitter

🤔 Is it time to routinely use ctDNA to guide #CRC adjuvant therapy? Experts discuss in #ASCODailyNews: fal.cn/3nBLR #GICSM

#queensu expert Chris Booth @QueensOncology Queen's Health Sciences writes for the Toronto Star about the five questions you should ask your oncologist when you are diagnosed with cancer. thestar.com/opinion/contri…

Excited for my #superstar 🌟 #medicaloncology colleague Dr. Safiya Karim (@zencancermd) who moderates an important ASCO session today on the role of #realworld #data 📊 in #oncology and #cancercare. Don’t miss it! #ASCO2022 OncoAlert UCalgaryMedicine AHS_CancerCare Oncology Outcomes (O2)

Call for Papers! Special Issue: We invite submissions that advance the understanding of the disparities in cancer care amongst medically underserved and rural populations. ➡️mdpi.com/journal/curron…

CW oncology can be impactful in LMICs. However, ground-level implementation requires concerted efforts at multiple levels, including patient, provider, health system, and societal levels.mdpi.com/1718-7729/29/7… Nazik Hammad @zencancermd Bishal Gyawali, MD, PhD, FASCO Rwanda Military Hosp Cancer Care and Epidemiology - Queen's University

Most of us avoid or delay uncomfortable conversations even with people who sit beside us. When your teammate is two time zones away, it’s far too easy for concerns to fester. hbr.org/2018/03/how-be…

Wonderful to get together at the annual UCalgaryMedicine Department of Oncology Recognition dinner, in person finally! UCalgary Psychosocial Oncology fared well and we won the Team Award for Innovation for our #IntegrativeOncology clinic!

Nurses’ Health Study, NHS II, and Health Professionals Follow-up Study: 🔸Precursors of colorectal cancer are linked to higher ultra-processed food (UPF) intake. 🔸UPFs may be a modifiable target for the early prevention of colorectal cancer. OncoAlert doi.org/10.1093/jnci/d…

#BOOW23 #Vancouver Listening to @zencancermd review the #ChoosingWisely campaign in 🇨🇦 cancer care ➡️ ‘less’ can be more OncologyEducation Canadian Partnership Against Cancer Canadian Association of Medical Oncologists Daniel Heng

SPOTLIGHT - FOLFOX +/- Zolbe 1L HER2- mGC/GEJ #GI23 ⭐️ 38.5% CLDN+🎯 📌 mPFS 10.6v8.6m HR 0.75 ✅ 📌 mOS 18.2v15.5m HR 0.75 ✅ 📌ORR 60% in both ⬆️N,V w/ Zolbe ⭐️ a new SOC for HER2- Question will be IO vs Zolbe? - stratify by PDL1? Congrats to Kohei shitara etal OncoAlert

Excited to share our publication on Choosing Wisely Canada cancer list - are the recommendations relevant and up to date with current evidence? Excited to continue work in this area to reduce low value care in oncology. authors.elsevier.com/a/1gUEd7tJEDS6…

.@zencancermd presents Alberta pop based data on treatment patterns for 1L mHSPC. Use of Tx intensification increasing over time #cua23

Check out the most recent Choosing Wisely Oncology Canada Cancer List. Lots of opportunities to decrease low-value care! Choosing Wisely Canada Canadian Association of Medical Oncologists sciencedirect.com/science/articl…

Our study showing practice patterns have changed to shorter duration of adjuvant chemotherapy in low-risk stage III colon cancer post publication of the IDEA collaboration study. ascopubs.org/doi/10.1200/OP… JCO Oncology Practice